Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860558 · ClinicalTrials.gov registry record · NA
Impact of Metabolic Health on Sperm Epigenetic Marks in Humans
A NA study of Overweight and Type 2 Diabetes Mellitus, sponsored by Joslin Diabetes Center.
- Active
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03860558: Active NA study of Overweight and Type 2 Diabetes Mellitus, sponsored by Joslin Diabetes Center.
NCT03860558 is a NA study of Overweight and Type 2 Diabetes Mellitus that is active but no longer recruiting, run by Joslin Diabetes Center. The registered enrollment target is 40 participants, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860558, a NA study of Overweight and Type 2 Diabetes Mellitus, is active but no longer recruiting, sponsored by Joslin Diabetes Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is designed to evaluate whether epigenetic markers in overweight men with type 1 diabetes (T1D) or type 2 diabetes (T2D) can be improved with a 3 month lifestyle intervention or program focused in glycemic intervention.
Primary Outcome
Sperm will be assessed for concentration, reported as total yield (millions per ml)
Conditions Studied
Interventions
- OTHER No Intervention
- OTHER Lifestyle Intervention
Study Locations (1)
Massachusetts
- Joslin Diabetes Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2026-07-01 |
| Phase | NA |
What the registry record for NCT03860558 still lists
NCT03860558 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,323-participant average among 197 other Overweight trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Overweight appearing as the primary indexed condition, and to 2 interventions - of which No Intervention is the first listed.
NCT03860558 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03860558 about?
NCT03860558 is a clinical study titled "Impact of Metabolic Health on Sperm Epigenetic Marks in Humans". This study is designed to evaluate whether epigenetic markers in overweight men with type 1 diabetes (T1D) or type 2 diabetes (T2D) can be improved with a 3 month lifestyle intervention or program focused in glycemic intervention.
What is the current status of trial NCT03860558?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2018-05-01. Estimated completion is 2026-07-01.
What conditions does trial NCT03860558 study?
This clinical trial studies the following conditions: Overweight, Type 2 Diabetes Mellitus, Type 1 Diabetes Mellitus.
What interventions are being tested in trial NCT03860558?
The interventions under investigation include: No Intervention (OTHER), Lifestyle Intervention (OTHER).
Who is sponsoring clinical trial NCT03860558?
This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03860558 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03860558's enrollment target sits among peer trials
40 157th of 197 higher than 39 of 197 other Overweight trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
-
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
RECRUITING · NA
-
Time Restricted Feeding, Muscle, and Metabolism
RECRUITING · NA
-
Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
RECRUITING · NA
-
Optimization of Chrononutrition to Reduce the Risk of Disease in Shift Workers
RECRUITING · NA
-
The Influence of Honey-flavored Yogurt on Low-grade Inflammation and Gut Health in Middle to Older Aged Women.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI